Edwards Lifesciences
1,272 hedge funds and large institutions have $46.5B invested in Edwards Lifesciences in 2023 Q2 according to their latest regulatory filings, with 119 funds opening new positions, 429 increasing their positions, 471 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 1,238 → 1,272 (+34)
0.01% less ownership
Funds ownership: 81.55% → 81.54% (-0.01%)
9% less repeat investments, than reductions
Existing positions increased: 429 | Existing positions reduced: 471
Holders
1,272
Holding in Top 10
18
Calls
$233M
Puts
$178M
Top Buyers
| 1 | +$130M | |
| 2 | +$118M | |
| 3 | +$114M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$92.5M |
| 5 |
Amundi
Paris,
France
|
+$83.9M |
Top Sellers
| 1 | -$238M | |
| 2 | -$146M | |
| 3 | -$116M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$93.1M |
| 5 |
JPMPWA
J.P. Morgan Private Wealth Advisors
San Francisco,
California
|
-$92.4M |